Moloney Securities Asset Management, LLC Northwest Biotherapeutics Inc Transaction History
Moloney Securities Asset Management, LLC
- $723 Million
- Q2 2025
A detailed history of Moloney Securities Asset Management, LLC transactions in Northwest Biotherapeutics Inc stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 501,560 shares of NWBO stock, worth $110,343. This represents 0.02% of its overall portfolio holdings.
Number of Shares
501,560
Previous 500,120
0.29%
Holding current value
$110,343
Previous $115,000
4.35%
% of portfolio
0.02%
Previous 0.02%
Shares
22 transactions
Others Institutions Holding NWBO
# of Institutions
12Shares Held
756KCall Options Held
0Put Options Held
0-
Vsm Wealth Advisory, LLC Hunt Valley, MD65.6KShares$14,4260.01% of portfolio
-
Opus Capital Group, LLC60.2KShares$13,2330.0% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA49.1KShares$10,7910.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY27KShares$5,9400.0% of portfolio
-
Alpha Mark Advisors, LLC Ft. Wright, KY14KShares$3,0810.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $228M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...